Stephen Jnr

105 posts

Stephen Jnr banner
Stephen Jnr

Stephen Jnr

@stephenjnr_dr

Medic 🩺 || The Blues || @BioProtocol || #DESCI

DeSci Katılım Haziran 2025
44 Takip Edilen36 Takipçiler
Sabitlenmiş Tweet
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
What PeptAI Truly Represents It goes beyond merely using AI to generate drug candidates. It's a system of autonomous agents that continuously conduct peptide discovery from research through to wet-lab validation.
Stephen Jnr tweet media
PeptAI@peptai_

Introducing PeptAI A fleet of autonomous agents for peptide drug discovery. PeptAI removes the handoffs between discovery, synthesis, and wet-lab validation, the parts that slow most pipelines down. How it works: > Runs a 9-gate pipeline (8 computational gates and 1 wet-lab gate) 24/7 > Publishes every gate decision openly and in real time via @Molecule_sci Labs > Automatically pays from its own wallet for wet-lab experiments (SPR validation via @adaptyvbio) when gate milestones are reached > Learns from wet-lab results and refines candidates across multiple runs The fleet: → Agent-01: GLP-1R, metabolic health: 35 candidates advancing → Agent-02: KISS1R, fertility: 2 of 10 advanced to G9 → Agent-03: OX2R, ADHD: lead candidate ready for wet lab → Agent-04: community-selected target: queued The fleet scales with budget. Each agent runs the same 9-gate pipeline against its receptor, 24/7. There are plenty of AI drug discovery pipelines. Most still have humans deciding which candidates advance. PeptAI's agent makes those calls itself, gate by gate. Candidates have to clear 8 computational gates to earn a wet-lab recommendation. Depending on the gate, the candidate is redesigned or discarded. Every decision is published on-chain. PeptAI runs on a stack of open scientific tools and protocols: > BIOS @bioaidevs: knowledge layer for literature search and novelty checks. When an agent needs to know what's been discovered or what the literature says about a target, it calls BIOS. > Litefold @try_litefold: molecular dynamics for conformational stability across G5 > Adaptyv Bio @adaptyvbio: wet-lab synthesis and SPR validation at G9 > Molecule Labs @Molecule_sci: on-chain publication of every gate decision in real time > @base: x402 infrastructure for machine-to-machine payments What you can do with PeptAI: • Follow along here for gate decisions, candidates, and updates as the pipeline runs • Use the open methodology to benchmark your own pipeline against the gates PeptAI is experimental and actively evolving. Gates, tools, and thresholds change as it learns. Discover PeptAI now: app.bio.xyz/agents/peptai

English
7
4
12
503
Stephen Jnr retweetledi
Bio Africa
Bio Africa@BioProtocolAF·
Less than 24 hours remain until the @peptai_ Ignition Sale wraps up on @BioProtocol. What began as just another DeSci launch has rapidly turned into one of the most followed sales in the ecosystem: → 19 times oversubscribed → Over 950K USDC committed → More than 1,200 participants It's easy to see why there's so much interest PeptAI isn't merely another AI trend, it's developing autonomous peptide drug discovery agents that can continually research, refine candidates, and move towards wet-lab validation. Clearly, the market is paying attention to where AI-driven biotech is headed next.
Bio Africa tweet media
English
5
4
36
4.2K
Bio Africa
Bio Africa@BioProtocolAF·
➤ PeptAI Ignition Sale is Ending Soon The PeptAI Ignition Sale within the @BioProtocol ecosystem is now entering its final 2 days. We are currently experiencing a 16.88x oversubscription, indicating strong demand as the deadline approaches. @peptai_ is part of Bio’s BioAgents framework AI agents designed to function within decentralized science workflows, enhancing structured intelligence throughout the ecosystem. 📌 Key points: ⇥ Ignition Sale concludes in 2 days ⇥ 16.88x oversubscribed participation ⇥ Developed as a BioAgent within the Bio.xyz infrastructure ⇥ Entry remains open, but closing quickly This is the last chance before allocations become limited. If you’re considering participation, this is your opportunity don’t wait until later. ➤ Participate here: app.bio.xyz/agents/peptai
Bio Africa tweet media
English
1
5
41
2.5K
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
Two days after staking more than 1,000 $BIO, I've already exceeded 700 BioXP on @BioProtocol. I'm steadily strengthening my position within the ecosystem, boosting my chances for upcoming Ignition Sales, and backing the long-term vision centered on DeSci.
Stephen Jnr tweet media
English
0
0
0
300
Stephen Jnr retweetledi
𝕊𝕋𝔼ℙℍ𝔼ℕ 𝕁ℕℝ
I just won my Silver trade on @trylimitless @trylimitlessfin 🔥 Silver was holding strong just like I thought. Loving these hourly moves fr.
𝕊𝕋𝔼ℙℍ𝔼ℕ 𝕁ℕℝ tweet media
𝕊𝕋𝔼ℙℍ𝔼ℕ 𝕁ℕℝ@0xStephenJnr

I just bought Up on Silver (XAG) Hourly on @trylimitlessfin @trylimitless Thesis : Silver’s been holding key levels well, so I’m expecting it to push a bit higher over the next hour. I feeling bullish on this one. limitless.exchange/share/8db50f55…

English
3
1
9
197
Stephen Jnr retweetledi
𝕊𝕋𝔼ℙℍ𝔼ℕ 𝕁ℕℝ
I'm enjoying this platform called @trylimitlessfin @trylimitless I took HYPE up for the 15 min move and it went above $41.409 before expiry. I just went with how price was holding and it played out clean.
𝕊𝕋𝔼ℙℍ𝔼ℕ 𝕁ℕℝ tweet media
𝕊𝕋𝔼ℙℍ𝔼ℕ 𝕁ℕℝ@0xStephenJnr

Took this on @trylimitlessfin @trylimitless Price has been holding up well around this area instead of breaking down, so I’m expecting another push above $41.409 before the 15 mins ends. Wish me luck chads limitless.exchange/share/d01ac566…

English
2
2
7
165
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
What truly stands out is the direction this indicates: AI agents are not merely assisting science; they are actively driving elements of the discovery pipeline with genuine validation loops.
Stephen Jnr tweet media
English
0
0
0
5
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
The PeptAI Ignition Sale concludes in 2 days. It has already been oversubscribed by 16.8 times on @BioProtocol, reflecting strong interest and demand for the project with over 1000+ participants.
Stephen Jnr tweet media
English
1
0
0
22
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
Introducing @peptai_: A system of autonomous agents designed for peptide drug discovery, which creates candidates, operates computational gates, and advances only the most promising ones towards wet-lab validation.
Stephen Jnr tweet media
English
1
0
0
30
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
@BrainsRET_ @peptai_ The 15x oversubscription is impressive, but what @peptai_ is building is the real story, AI agents doing continuous drug discovery and learning from real validation results feels much bigger than a normal AI narrative.
English
0
0
0
10
Brainy 🕳️
Brainy 🕳️@BrainsRET_·
Weekend Update : $PEPTAI is now 15× oversubscribed on Bio ignition sale so you ask: what is @peptai_ Read this and see why I'm predicting a 10-15x return on their token sale: - Right now, Everyone is focused on AI agents but nobody is talking about AI agents discovering medicine. That’s what @peptai_ is trying to build, A system that allows AI agent research 24/7: - Improves speed and productivity for medical discoveries . Why They can Pull a 10-15x Minimum: - @BioProtocol Minshare is at peak right now & Attention = Liquidity. - Past Ignition sale such as $Aubrai and $D1ck were launched after periods of dry market and they pulled 100 & 30× respectively. $PeptAi is been launched at such a time . - Unique Tek in medical Discovery which is already working. Lastly, The entire market is hot right now🔥 Put this together and understand the upside here at $1m FDV. If Memes like Hantavirus add $10m+ in a day, why not this ? Go and have exposure right now on app.bio.xyz/agents/peptai - Bid USDc and BioXp to participate in the sale . As usual, This is not a Financial advice ! Do your own Research and enjoy your weekend.
Brainy 🕳️ tweet mediaBrainy 🕳️ tweet media
Brainy 🕳️@BrainsRET_

Quick recap so you don't have to read all that: - $PeptAI is 12.9× oversubscribed with 610K USDC committed by 650+ users. 20% of the token supply will be distributed to veBIO holders. - Anyone with USDC can now participate in ignition sales but #BioXP gives priority when sales are oversubscribed. - BIOs AI got smarter and with a Faster chat mode. - @vitadao project got acquired by Eli Lilly for $300M . #Desci is winning and I can feel it .

English
10
3
34
6.9K
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
I just increased my $BIO stake to achieve Level 2 and locked it in until 2028 on @BioProtocol. This will provide me with more BioXP and a stronger position for future Ignition Sales. I really appreciate the direction Bio is taking with AI scientists and DeSci infrastructure.
Stephen Jnr tweet media
English
0
0
4
327
Bio Protocol
Bio Protocol@BioProtocol·
Join us TOMORROW for a live demo of the upcoming features in the BIOS AI Scientist w/ @BioAIDevs > New biotech tool integrations > Segmentation > A look at what's shipping next Register below ↓
Bio Protocol tweet media
English
18
20
126
7.2K
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
A lot of attention is on the @peptai_ sale right now, but BIOS deserves way more attention too. PeptAI shows what autonomous biotech can look like. BIOS is the AI scientist powering a lot of that direction behind the scenes. @BioProtocol
MRCY🐾@Thismrcy11

I know everyone’s eyes are glued to the PeptAI Ignition Sale on Bio launchpad right now, and for good reasons. It hit 100% of the 50K USDC goal in no time, now sitting at a crazy 16.4X oversubscription with over 822K USDC and 590M+ BioXP contributed. But while the sale is popping off, a lot of us are not paying attention to something equally bigger that’s already live and shipping: BIOS. BIOS (chat.bio.xyz) is Bio Protocol’s autonomous AI Scientist which is your personal research assistant for complex biomedical questions. It was launched late January 2026 and has quickly become one of the most advanced tools in DeSci. What it does: • Orchestrates Literature + Data Analysis agents that actually read papers, refine hypotheses, run Python code, and build persistent memory across sessions • Modes from Steering (you control every step) to Autonomous Deep (runs for hours) • Currently #1 on BixBench with 48.78% accuracy beating much bigger models In the screenshot you can see it greeting you and listing everything it can help with: experiment planning, evidence synthesis, mechanism understanding, clinical trials, drug development, longevity research… basically anything in life sciences. This is the real agentic science layer powering tools like PeptAI. While the sale funds the next breakthroughs, BIOS is the engine actually doing the science right now. If you’re into DeSci, don’t just partake in the sale, go try BIOS too (free for .edu emails in early access). Still a few days to participate in the @peptai_ sale: pledge your BioXP + USDC on the launchpad before it closes. @BioProtocol

English
1
0
2
71
Stephen Jnr
Stephen Jnr@stephenjnr_dr·
Agents can move faster than humans now they read, analyze, and generate ideas nonstop. But humans still provide judgment, direction, and context The future probably isn’t AI replacing researchers it’s building spaces where both can work together without slowing each other down.
Bio Protocol@BioProtocol

Agents read papers, draft hypotheses, run queries, and propose experiments faster than any human can keep up with. Humans still need to validate, steer, and decide what actually matters. That gap in speed is what the new collaboration really looks like. What’s missing is a shared surface where both can move at their own pace and still work on the same project.

English
0
0
0
9